These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 35833892)

  • 1. Expression and therapeutic targeting of BMI1 in canine gliomas.
    Al-Nadaf S; Peacott-Ricardos KS; Dickinson PJ; Rebhun RB; York D
    Vet Comp Oncol; 2022 Dec; 20(4):871-880. PubMed ID: 35833892
    [TBL] [Abstract][Full Text] [Related]  

  • 2. BMI1 is expressed in canine osteosarcoma and contributes to cell growth and chemotherapy resistance.
    Shahi MH; York D; Gandour-Edwards R; Withers SS; Holt R; Rebhun RB
    PLoS One; 2015; 10(6):e0131006. PubMed ID: 26110620
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Combined aberrant expression of Bmi1 and EZH2 is predictive of poor prognosis in glioma patients.
    Wu Z; Wang Q; Wang L; Li G; Liu H; Fan F; Li Z; Li Y; Tu Y
    J Neurol Sci; 2013 Dec; 335(1-2):191-6. PubMed ID: 24139839
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular signalling pathways in canine gliomas.
    Boudreau CE; York D; Higgins RJ; LeCouteur RA; Dickinson PJ
    Vet Comp Oncol; 2017 Mar; 15(1):133-150. PubMed ID: 25808605
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Copy number alterations of the polycomb gene BMI1 in gliomas.
    Häyry V; Tanner M; Blom T; Tynninen O; Roselli A; Ollikainen M; Sariola H; Wartiovaara K; Nupponen NN
    Acta Neuropathol; 2008 Jul; 116(1):97-102. PubMed ID: 18427816
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Silencing BMI1 eliminates tumor formation of pediatric glioma CD133+ cells not by affecting known targets but by down-regulating a novel set of core genes.
    Baxter PA; Lin Q; Mao H; Kogiso M; Zhao X; Liu Z; Huang Y; Voicu H; Gurusiddappa S; Su JM; Adesina AM; Perlaky L; Dauser RC; Leung HC; Muraszko KM; Heth JA; Fan X; Lau CC; Man TK; Chintagumpala M; Li XN
    Acta Neuropathol Commun; 2014 Dec; 2():160. PubMed ID: 25526772
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Acute myeloid leukemia driven by the CALM-AF10 fusion gene is dependent on BMI1.
    Barbosa K; Deshpande A; Chen BR; Ghosh A; Sun Y; Dutta S; Weetall M; Dixon J; Armstrong SA; Bohlander SK; Deshpande AJ
    Exp Hematol; 2019 Jun; 74():42-51.e3. PubMed ID: 31022428
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A miR-200c/141-BMI1 autoregulatory loop regulates oncogenic activity of BMI1 in cancer cells.
    Dimri M; Kang M; Dimri GP
    Oncotarget; 2016 Jun; 7(24):36220-36234. PubMed ID: 27105531
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Downregulation of Bmi1 in breast cancer stem cells suppresses tumor growth and proliferation.
    Srinivasan M; Bharali DJ; Sudha T; Khedr M; Guest I; Sell S; Glinsky GV; Mousa SA
    Oncotarget; 2017 Jun; 8(24):38731-38742. PubMed ID: 28418883
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A novel zinc finger protein Zfp277 mediates transcriptional repression of the Ink4a/arf locus through polycomb repressive complex 1.
    Negishi M; Saraya A; Mochizuki S; Helin K; Koseki H; Iwama A
    PLoS One; 2010 Aug; 5(8):e12373. PubMed ID: 20808772
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Potential role of Shh-Gli1-BMI1 signaling pathway nexus in glioma chemoresistance.
    Shahi MH; Farheen S; Mariyath MP; Castresana JS
    Tumour Biol; 2016 Nov; 37(11):15107-15114. PubMed ID: 27662839
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nuclear-encoded cytochrome c oxidase subunit 4 regulates BMI1 expression and determines proliferative capacity of high-grade gliomas.
    Oliva CR; Markert T; Gillespie GY; Griguer CE
    Oncotarget; 2015 Feb; 6(6):4330-44. PubMed ID: 25726526
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The BMI1 inhibitor PTC-209 is a potential compound to halt cellular growth in biliary tract cancer cells.
    Mayr C; Wagner A; Loeffelberger M; Bruckner D; Jakab M; Berr F; Di Fazio P; Ocker M; Neureiter D; Pichler M; Kiesslich T
    Oncotarget; 2016 Jan; 7(1):745-58. PubMed ID: 26623561
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Epigenetic regulation of survivin by Bmi1 is cell type specific during corticogenesis and in gliomas.
    Acquati S; Greco A; Licastro D; Bhagat H; Ceric D; Rossini Z; Grieve J; Shaked-Rabi M; Henriquez NV; Brandner S; Stupka E; Marino S
    Stem Cells; 2013 Jan; 31(1):190-202. PubMed ID: 23132836
    [TBL] [Abstract][Full Text] [Related]  

  • 15. BMI1 Inhibitors Down-regulate NOTCH Signaling and Suppress Proliferation of Acute Leukemia Cells.
    Ohtaka M; Itoh M; Tohda S
    Anticancer Res; 2017 Nov; 37(11):6047-6053. PubMed ID: 29061784
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression and targeting of transcription factor ATF5 in dog gliomas.
    York D; Sproul CD; Chikere N; Dickinson PJ; Angelastro JM
    Vet Comp Oncol; 2018 Mar; 16(1):102-107. PubMed ID: 28480569
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MicroRNA‑128a, BMI1 polycomb ring finger oncogene, and reactive oxygen species inhibit the growth of U‑87 MG glioblastoma cells following exposure to X‑ray radiation.
    Ye L; Yu G; Wang C; Du B; Sun D; Liu J; Qi T; Yu X; Wei W; Cheng J; Jiang Y
    Mol Med Rep; 2015 Oct; 12(4):6247-54. PubMed ID: 26238021
    [TBL] [Abstract][Full Text] [Related]  

  • 18. BMI1 cooperates with H-RAS to induce an aggressive breast cancer phenotype with brain metastases.
    Hoenerhoff MJ; Chu I; Barkan D; Liu ZY; Datta S; Dimri GP; Green JE
    Oncogene; 2009 Aug; 28(34):3022-32. PubMed ID: 19543317
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Distinctive expression of the polycomb group proteins Bmi1 polycomb ring finger oncogene and enhancer of zeste homolog 2 in nonsmall cell lung cancers and their clinical and clinicopathologic significance.
    Kikuchi J; Kinoshita I; Shimizu Y; Kikuchi E; Konishi J; Oizumi S; Kaga K; Matsuno Y; Nishimura M; Dosaka-Akita H
    Cancer; 2010 Jun; 116(12):3015-24. PubMed ID: 20564407
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [PRODUCT OF THE BMI1--A KEY COMPONENT OF POLYCOMB--POSITIVELY REGULATES ADIPOCYTE DIFFERENTIATION OF MOUSE MESENCHYMAL STEM CELLS].
    Petrov NS; Vereschagina NA; Sushilova EN; Kropotov AV; Miheeva NF; Popov BV
    Tsitologiia; 2016; 58(2):83-90. PubMed ID: 27228653
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.